Scientific Sessions 2024  /  New Targets and New Treatments: Advances in Lipid Therapeutics  /  History and future of lipid therapeutics- a time of Renaissance
Logo

American Heart Association

  21
  0

Final ID:

History and future of lipid therapeutics- a time of Renaissance

  • Rader, Daniel  ( UNIVERSITY OF PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
  • Morris, Pamela  ( MEDICAL UNIVERSITY OF SC , Mt Pleasant , South Carolina , United States )
    • Author Disclosures:
    Daniel Rader: DO have relevant financial relationships ; Consultant:Alnylam:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:Novartis:Active (exists now) | Pamela Morris: DO have relevant financial relationships ; Researcher:Esperion:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

New Targets and New Treatments: Advances in Lipid Therapeutics

Monday, 11/18/2024 , 01:30PM - 02:45PM

Late-Breaking Science

More abstracts on this topic:
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles

Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John

Discussant: CETP inhibition-is it time for a revival?

Watson Karol

More abstracts from these authors:
Exome-wide association study of over a million individuals identified effector genes and variants for blood lipids

Koyama Satoshi, Dron Jacqueline, Spinks Catherine, Surakka Ida, Hornsby Whitney, Damrauer Scott, Chang Kyong-mi, Assimes Themistocles, Tsao Philip, Rader Daniel, Kim Kelly, Yu Zhi, Peloso Gina, Ellinor Patrick, Sun Yan, Wilson Peter, Natarajan Pradeep, Choi Seung Hoan, Jurgens Sean, Selvaraj Margaret, Klarin Derek, Huffman Jennifer, Trinh Michael, Ravi Akshaya

Hypertension and AI based clinic guidance

Rader Daniel, Khera Amit, Kelly Melissa, Ebinger Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available